Naloxone: FDA approves over-the-counter Narcan nasal spray, with Bobby Mukkamala, MD episode artwork

EPISODE · Apr 26, 2023 · 11 MIN

Naloxone: FDA approves over-the-counter Narcan nasal spray, with Bobby Mukkamala, MD

from AMA Update · host American Medical Association

Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, joins to discuss what FDA's recent approval of OTC naloxone means for doctors and patients—as well as how to administer Narcan in an emergency. The life-saving medication can reverse an overdose from fentanyl, oxycodone and other opioids. American Medical Association CXO Todd Unger hosts. Visit https://end-overdose-epidemic.org for more information on AMA’s efforts to end the overdose epidemic. 

Episode metadata supplied by the publisher feed · Published Apr 26, 2023

Embed this episode

NOW PLAYING

Naloxone: FDA approves over-the-counter Narcan nasal spray, with Bobby Mukkamala, MD

0:00 11:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AMA Update?

This episode is 11 minutes long.

When was this AMA Update episode published?

This episode was published on April 26, 2023.

Can I download this AMA Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!